跳至主要内容
临床试验/JPRN-UMIN000041513
JPRN-UMIN000041513招募中未知

A new perioperative glucocorticosteroid replacement therapy for cushing syndrome - A perioperative glucocorticosteroid replacement therapy

Tianjin Medical University General Hospital0 个研究点目标入组 83 人开始时间: 2020年9月1日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
83

研究概览

简要总结

Adrenal insufficiency and steroid withdrawal syndrome were not occurred with all patients. Compared with the concentration of urine cortisol preoperation, it was significantly decreased on the day 7 postoperative. Plasma cortisol concentration was significantly decreased on the day 6 postoperative compared with preoperative. All the patients were followed up to 6 months,plasma cortisol and 24h urine cortisol levels were all normal.

研究设计

研究类型
Interventional

入排标准

年龄范围
22years-old 至 61years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patients who had unilateral or bilateral adrenal tumor or nodule but not accepted adrenal gland surgery were excluded in this study.

研究者

相似试验

进行中(未招募)
不适用
Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacement10 male patients with hypopituitarism resulting in ACTH (adrenocorticotropin) deficiency (ICD E23.0) will be studied on varying doses of hydrocortisone replacement therapy. THis is not a new medication for these patients.10 healthy male volunteers will be studied as control subjects. They will NOT receive hydrocortisone.MedDRA version: 9.1Level: LLTClassification code 10021067Term: HypopituitarismMedDRA version: 9.1Level: LLTClassification code 10033662Term: PanhypopituitarismMedDRA version: 9.1Level: LLTClassification code 10057217Term: Isolated ACTH deficiency
EUCTR2007-005018-37-IEAmar Agha20
已完成
不适用
Glucocorticoid replacement therapy and fibrinolysis.utritional, Metabolic, Endocrine: HypopituitarismNutritional, Metabolic, EndocrineHypopituitarism
ISRCTN93511659Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)25
进行中(未招募)
1 期
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockSeptic Shock
EUCTR2012-003158-10-IEThe George Institute for Global Health3,800
进行中(未招募)
1 期
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockSeptic Shock
EUCTR2012-003158-10-DKThe George Institute for Global Health3,800
进行中(未招募)
不适用
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockMedDRA version: 16.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestationsSeptic Shock
EUCTR2012-003158-10-GBThe George Institute for Global Health3,800
A new perioperative glucocorticosteroid replacement... | 临床试验